Tech Company Financing Transactions

HealthTell Funding Round

On 9/30/2014, HealthTell raised $3.1 million in financing from Paladin Capital Group.

Transaction Overview

Company Name
Announced On
9/30/2014
Transaction Type
Venture Equity
Amount
$3,118,000
Round
Undisclosed
Investors

Paladin Capital Group (Paul Conley)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2420 Camino Ramon 125
San Ramon, CA 94583
USA
Email Address
Overview
The core of HealthTell's diagnostic platform are Antibodies. Our technology produces an Immunosignature: a real time, disease specific health status--all from a single drop of blood.
Profile
HealthTell LinkedIn Company Profile
Social Media
HealthTell Company Twitter Account
Company News
HealthTell News
Facebook
HealthTell on Facebook
YouTube
HealthTell on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
William Colston
  William Colston LinkedIn Profile  William Colston Twitter Account  William Colston News  William Colston on Facebook
Chief Information Officer
Donald Morris
  Donald Morris LinkedIn Profile  Donald Morris Twitter Account  Donald Morris News  Donald Morris on Facebook
VP - Bus. Development
Isaac Bright
  Isaac Bright LinkedIn Profile  Isaac Bright Twitter Account  Isaac Bright News  Isaac Bright on Facebook
VP - Bus. Development
Glen Ferguson
  Glen Ferguson LinkedIn Profile  Glen Ferguson Twitter Account  Glen Ferguson News  Glen Ferguson on Facebook
VP - Finance
Myla Puyat
  Myla Puyat LinkedIn Profile  Myla Puyat Twitter Account  Myla Puyat News  Myla Puyat on Facebook
VP - Operations
David Smith
  David Smith LinkedIn Profile  David Smith Twitter Account  David Smith News  David Smith on Facebook
VP - Product Management
Ted Tarasow
  Ted Tarasow LinkedIn Profile  Ted Tarasow Twitter Account  Ted Tarasow News  Ted Tarasow on Facebook
VP - R & D
Kathryn Sykes
  Kathryn Sykes LinkedIn Profile  Kathryn Sykes Twitter Account  Kathryn Sykes News  Kathryn Sykes on Facebook
VP - Regulatory Affairs
Gary Riordan
  Gary Riordan LinkedIn Profile  Gary Riordan Twitter Account  Gary Riordan News  Gary Riordan on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/30/2014: Five Star Technologies venture capital transaction
Next: 9/30/2014: Betabrand venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary